Clinical Trial Update: Brentuximab Vedotin in Early Stage Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Brentuximab vedotin in early-stage Hodgkin lymphoma is currently recruiting. The sponsor listed is University College London…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: University College, London | Conditions: Hodgkin Lymphoma | Phase 3 | Status: RECRUITING